122 related articles for article (PubMed ID: 15795351)
1. The likelihood that PSA detection of early prostate cancers is associated with high mortality.
Louria DB
Arch Intern Med; 2005 Mar; 165(6):702. PubMed ID: 15795351
[No Abstract] [Full Text] [Related]
2. Prostate specific antigen: a useful screening test?
Concato J
Cancer J; 2000 Apr; 6 Suppl 2():S188-92. PubMed ID: 10803835
[TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
Carroll PR; Whitson JM; Cooperberg MR
J Clin Oncol; 2011 Feb; 29(4):345-7. PubMed ID: 21189396
[No Abstract] [Full Text] [Related]
4. 4-year prostate specific antigen progression and diagnosis of prostate cancer in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
Schröder FH; Raaijmakers R; Postma R; van der Kwast TH; Roobol MJ
J Urol; 2005 Aug; 174(2):489-94; discussion 493-4. PubMed ID: 16006878
[TBL] [Abstract][Full Text] [Related]
5. Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation.
Connolly D; Black A; Gavin A; Keane PF; Murray LJ
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):271-8. PubMed ID: 18250343
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen and prostate cancer prognosis.
Church TR
J Natl Cancer Inst; 2006 Nov; 98(21):1509-10. PubMed ID: 17077347
[No Abstract] [Full Text] [Related]
8. Can we accurately identify men with low risk prostate cancer?
Neal DE
J Urol; 2008 Oct; 180(4):1217-8. PubMed ID: 18707718
[No Abstract] [Full Text] [Related]
9. Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancer.
Loeb S; Carter HB
Urol Oncol; 2009; 27(6):583-4. PubMed ID: 19879470
[No Abstract] [Full Text] [Related]
10. Prostate-specific antigen dynamics and prostate cancer diagnosis.
Bartoletti R
Eur Urol; 2009 Nov; 56(5):761-2; discussion 763. PubMed ID: 19665286
[No Abstract] [Full Text] [Related]
11. Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence.
Etzioni RD; Ankerst DP; Weiss NS; Inoue LY; Thompson IM
J Natl Cancer Inst; 2007 Oct; 99(20):1510-5. PubMed ID: 17925534
[TBL] [Abstract][Full Text] [Related]
12. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
Höltl W; Lunglmayr G
Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
[No Abstract] [Full Text] [Related]
13. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
14. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
15. Survival benefit confirmed for prostate cancers diagnosed by PSA testing.
Lamb DS; Delahunt B; Denham J; Slaney D
N Z Med J; 2009 Jul; 122(1299):67-70. PubMed ID: 19684649
[No Abstract] [Full Text] [Related]
16. PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence.
Perrin P
Eur Urol; 2006 Mar; 49(3):418-9. PubMed ID: 16459016
[No Abstract] [Full Text] [Related]
17. [PSA level--is 4.0 ng/ml as upper limit too high].
Aktuelle Urol; 2005 Jun; 36(3):181-8. PubMed ID: 16001334
[No Abstract] [Full Text] [Related]
18. Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millennium.
Djavan B
Eur Urol; 2010 Jun; 57(6):928-9. PubMed ID: 20304552
[No Abstract] [Full Text] [Related]
19. Prostate cancer risk assessment program: a 10-year update of cancer detection.
Giri VN; Beebe-Dimmer J; Buyyounouski M; Konski A; Feigenberg SJ; Uzzo RG; Hanks G; Godwin AK; Chen DY; Gordon R; Cescon T; Raysor S; Watkins-Bruner D
J Urol; 2007 Nov; 178(5):1920-4; discussion 1924. PubMed ID: 17868726
[TBL] [Abstract][Full Text] [Related]
20. [Early detection of cancer of the prostate. Pros and cons].
Hoesl CE; Altwein JE
MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]